News and Insights from Our Multidisciplinary Team of Experts
TissueInsight Immuno-Oncology Service Offers Data for Advanced Cancer Patient CareJune 30, 2020 — Flagship Biosciences, providers of expert tissue data insights, today announced the launch of a new clinical diagnostics immuno-oncology service, TissueInsight....
Flagship Biosciences recently hosted a webcast on Biomarkers: Strategies and Implementation, and Drug Development. Introduced by our COO Meredith James, we were pleased to have our colleague Suzana Corritori, MD, PhD, MSc present her thoughts on a strategic approach...
Caroline Chandler, Flagship Project Manager, graduated from Colorado State University with a Bachelor of Science degree in sports medicine. Caroline shared her thoughts about her career and working at Flagship in this spotlight article.Early Cancer Treatment...
Cris Luengo, PhD, is Director of Image Analysis at Flagship Biosciences. Cris has a PhD in Image Analysis and an MSc in Applied Physics, both from Delft University of Technology, The Netherlands. Cris shared some experiences that led him to Flagship, as well as...
Westminster, CO — May 27, 2020 — Flagship Biosciences, providers of expert tissue data insights, today announced that Aymii Couzelis has been named to its executive team as Chief Information Officer. Aymii brings over 20 years of experience leading IT and product...
Mandy Bell is certified as a histotechnologist (HTL) by the American Society for Clinical Pathology (ASCP) and is the laboratory manager at Flagship Biosciences. Mandy received a BS in biology from Colorado State University. She said she has always wanted to be a...
Sign up to receive industry and company news, including The Cut Point, Flagship’s quarterly e-newsletter.
PUBLICATIONS/POSTERS
Key Takeaways Manual pathology assessment is challenging and variable, limiting the data interpretation required for meaningful spatial biology analysis Unlike manual assessment, artificial intelligence and machine learning technologies analyze the complex...
Key Takeaways Classifying macrophages is important in understanding response to immunotherapy, but it may be challenging to do by eye Using an immunofluorescence-guided machine learning algorithm provided accurate macrophage classification This algorithm is useful in...
ABSTRACT In vitro diagnostic (IVD) approvals of qualitative immunohistochemical (IHC) assays offer unique patient selection strategies by equipping pathologists with new tools to assess tumor status including tumor immune landscape. PD-L1/PD-1 checkpoint therapies...
EVENTS
Reuniting 100+ leading experts in biotech, pharma, and academia. February 21-23, 2023. We’re headed to Boston to join other leading experts in biotech, pharma and academia to discuss obstacles in clinical trials and strategies for delivering safer and more effective...
Join Flagship for the Oncology Companion Diagnostics Xchange at hubXchange West. February 6-9, 2023. Attending hubXchange West? Meet with us to discuss how we can partner with you for end-to-end support of your immunotherapy research and development program....
Visit Flagship at the SB-IO Summit.January 17-19, 2023. Attending the inaugural SB-IO Summit? Stop by our booth to discuss how we can partner with you for end-to-end support of your immunotherapy research and development program. AI-powered digital pathology solutions...